纳斯达克 -- -- --

最近浏览

齐默巴奥米特

NYSE:ZBH 延时15分钟
  • 今开:--
    昨收:--
  • 今日区间:--
    52周区间:--
  • 成交量:--
    成交额:--
  • 市 值:--
    市盈率:--
  • 振幅:
    每股收益:
成交量

董事会

Ivan Tornos
Ivan Tornos is currently Chairman, President & Chief Executive Officer at Zimmer Biomet Holdings, Inc. since 2025 and Chief Operating Officer at Zimmer US, Inc. since 2018. Former roles include President-Europe, Middle East & Africa Region at C. R. Bard, Inc. (New Jersey) from 2017 to 2018, Vice President-Business Development & Strategy at Baxter International, Inc., Worldwide President-Global Urology at Becton, Dickinson & Co., General Manager-Americas at Covidien Holding, Inc. from 2009 to 2011, and President at both Biomet, Inc. and Biomet Leasing, Inc. Education includes an undergraduate degree from Terry College of Business and an MBA from the University of Miami School of Business.
Arthur Joseph Higgins
Mr. Arthur J. Higgins is an Independent Director at Zimmer Biomet Holdings, Inc. He is on the Board of Directors at UNION Therapeutics A/S, Zimmer Biomet Holdings, Inc., Moksha8 Pharmaceuticals, Inc. and Nuvelution Pharma, Inc. Mr. Higgins was previously employed as a Non-Executive Chairman by Assertio Holdings, Inc., a Non-Executive Chairman by Assertio Therapeutics, Inc., an Independent Director by Endo International Plc, an Executive Chairman by Ascendancy Healthcare, Inc., a Member by Blackstone Healthcare Partners LLC, an Independent Director by Ecolab, Inc., an Independent Director by Resverlogix Corp., a President by European Federation of Pharmaceutical Industries & Assns, a Chairman by Bayer Schering Pharma AG, a Council Member by International Federation of Pharmaceutical Manufacturers, a Chairman-Management Board by Bayer HealthCare AG, a Chief Executive Officer by Bayer Healthcare LLC, a Chairman, President & Chief Executive Officer by Enzon Pharmaceuticals, Inc., a President-Pharmaceutical Products Division by Abbott Laboratories, a Principal by Fisons Ltd., a Principal by Geneva Pharmaceuticals, Inc., a Vice President by Bristol Myers Squibb Co., a Chairman by Bayer Schering Pharma AG /BE/, a Chairman by BioNJ, Inc., and a Chairman-Biotechnology Council by National Pharmaceutical Council. He also served on the board at Endo Health Solutions, Inc., Catalent Pharma Solutions, Inc., Zimmer US, Inc. and Pharmaceutical Research & Manufacturers of America. He received his undergraduate degree from the University of Strathclyde.
旧服务已下线,请迁移至 http://api.fanyi.baidu.com
Robert A. Hagemann
Robert A. Hagemann currently works at Ryder System, Inc., as Independent Director from 2014, Zimmer Biomet Holdings, Inc., as Independent Director from 2012, Celera Corp., as Director, and Graphic Packaging Holding Co., as Independent Director from 2014. Mr. Hagemann also formerly worked at Zimmer US, Inc., as Director, Prime Hospitality Corp., as Principal, Quest Diagnostics, Inc., as Chief Financial Officer & Senior Vice President from 2003 to 2013, Ernst & Young LLP, as Principal, Crompton & Knowles Corp., as Principal, Corning Life Sciences, Inc., as Vice President & Controller from 1992 to 2007, and Merrill Lynch & Co., Inc., as Principal. Mr. Hagemann received his undergraduate degree from Rider University and Masters Business Admin degree from Seton Hall University.
Betsy J. Bernard
Ms. Betsy J. Bernard is an Independent Director at Zimmer Biomet Holdings, Inc. and an Advisor at Grotech Management Co. She is on the Board of Directors at Leap Insurance Agency LLC, Zimmer US, Inc., Zimmer Biomet Holdings, Inc. and Principal Life Insurance Co. Ms. Bernard was previously employed as a Lead Independent Director by SITO Mobile Ltd., a Non-Executive Chairman by Telular Corp., a President by AT&T Business Services, a President by AT&T Corp. /Old/, a Chief Executive Officer & Executive Vice President by AT&T Consumer Services, Inc., an Independent Director by Principal Financial Group, Inc., an Executive Vice President-National Mass Markets by Qwest Communications International, Inc., an Executive Vice President-Retail by US West, Inc., a Principal by AVIRNEX Communications Group, a Principal by Pacific Bell Telephone Co., and a President & Chief Executive Officer by Pacific Telesis Group. She also served on the board at URS Corp., BearingPoint, Inc., United Technologies Corp., Principal Financial Services, Inc., Serco Group Plc and The International Women's Forum. She received her undergraduate degree from St. Lawrence University, a graduate degree from Stanford University and an MBA from Fairleigh Dickinson University.
Michael J. Farrell
Michael J. Farrell is Chairman & Chief Executive Officer at ResMed, Inc. since 2023, Chief Executive Officer at ResMed (UK) Ltd. since 2013, Chairman & Chief Executive Officer at ResMed Pty Ltd. since 2023, Chairman & Chief Executive Officer at ResMed Corp. since 2013, Chairman at Advanced Medical Technology Association since 2026, Lead Independent Director at Zimmer Biomet Holdings, Inc. since 2025, Director at The American Association for Homecare, Treasurer & Director at National Assn of Children's Hospitals & Related Institutions, Director at The New Children s Museum, Director at Primasun LLC, Trustee at S.V.D.P. Management, Inc., Trustee at San Diego Museum of Man, Trustee at Rady Children's Hospital Foundation-San Diego, and Trustee at UC San Diego Foundation. Former roles include Director at California Healthcare Institute, Director at The Medical Device Manufacturers Association, Director at Zimmer US, Inc., Principal at The Dow Chemical Co., Process Engineer at BHP Group Ltd., Consultant & Business Analyst at Genzyme Corp., Manager-Chemicals Practice at Arthur D. Little, Inc., and Trustee at La Jolla Playhouse, Inc. Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at The University of New South Wales, and an MBA from MIT Sloan School of Management.
Maria Teresa Hilado
Ms. Maria T. Hilado is an Independent Director at Galderma Group AG, an Independent Director at Galderma International SAS, an Independent Director at Curia Global, Inc., an Independent Director at Zimmer Biomet Holdings, Inc., an Independent Director at The Campbell's Co., a Director & Vice President at Kythera Biopharmaceuticals LLC and a Co-Chairman-Strong Kids Campaign at YMCA of Greater New York. She is on the Board of Directors at Galderma Group AG, Galderma International SAS, Curia Global, Inc., Zimmer Biomet Holdings, Inc., The Campbell's Co., Pharmaceutical Product Development LLC and Kythera Biopharmaceuticals LLC. Ms. Hilado was previously employed as an Independent Director by PPD, Inc., a Chief Financial Officer & Executive Vice President by Allergan Ltd. (Ireland), a Chief Financial Officer by Allergan, Inc., a Chief Financial Officer by Actavis, Inc., an Independent Director by H.B. Fuller Co., a Treasurer & Senior Vice President by PepsiCo, Inc., a Treasurer & Vice President by Schering-Plough Corp., a Chief Financial Officer by GMAC Commercial Finance LLC, a Chief Financial Officer by General Motors Acceptance Corp., an Assistant Treasurer by General Motors Corp., and a Chief Financial Officer & Treasurer by General Motors Co. She also served on the board at Bausch & Lomb, Inc. and Allergan GI Corp. She received her undergraduate degree from the University of Ateneo de Manila and an MBA from the University of Virginia Darden School of Business.
Syed A. Jafry
Mr. Syed A. Jafry is an Independent Director at Zimmer Biomet Holdings, Inc. He is on the Board of Directors at Antylia Scientific and Zimmer Biomet Holdings, Inc. Mr. Jafry was previously employed as a President by Thermo Fisher Scientific (China) Co., Ltd., a Senior Vice President & President-Regions by Thermo Fisher Scientific, Inc., and a President-GE Sensing Asia by General Electric (China) Co., Ltd. He received his undergraduate degree from The University of Lahore and a graduate degree from the University of Massachusetts.
Ivan Tornos
Ivan Tornos is currently Chairman, President & Chief Executive Officer at Zimmer Biomet Holdings, Inc. since 2025 and Chief Operating Officer at Zimmer US, Inc. since 2018. Former roles include President-Europe, Middle East & Africa Region at C. R. Bard, Inc. (New Jersey) from 2017 to 2018, Vice President-Business Development & Strategy at Baxter International, Inc., Worldwide President-Global Urology at Becton, Dickinson & Co., General Manager-Americas at Covidien Holding, Inc. from 2009 to 2011, and President at both Biomet, Inc. and Biomet Leasing, Inc. Education includes an undergraduate degree from Terry College of Business and an MBA from the University of Miami School of Business.
Sreelakshmi Kolli
Ms. Sreelakshmi Kolli is an Independent Director at Intuitive Surgical, Inc., an Independent Director at Zimmer Biomet Holdings, Inc. and an Executive VP, Chief Product & Digital Officer at Align Technology, Inc. She is on the Board of Directors at Intuitive Surgical, Inc. and Zimmer Biomet Holdings, Inc. She received her undergraduate degree from Bharathidasan University and a graduate degree from National Institute of Technology Tiruchirappalli.
Louis A. Shapiro
Mr. Louis A. Shapiro is an Independent Director at STERIS Plc (Ireland) and an Independent Director at Zimmer Biomet Holdings, Inc. He is on the Board of Directors at STERIS Plc (Ireland), Zimmer Biomet Holdings, Inc. and Hospital for Special Surgery. Mr. Shapiro was previously employed as a Chairman by Greater New York Hospital Association, Inc., a Chief Operating Officer & Executive Vice President by Geisinger Health System Foundation, a President & Chief Executive Officer by HSS Ventures, Inc., a President by Medical Indemnify Assurance Co., and a Member by Rightmove Health LLC. He received his undergraduate degree from the University of Pittsburgh and a graduate degree from the University of Pittsburgh Graduate School of Public Health.
Devdatt Kurdikar
Dr. Devdatt Kurdikar is an Independent Director at Zimmer Biomet Holdings, Inc. and a Chairman, President & Chief Executive Officer at Embecta Corp. He is on the Board of Directors at Zimmer Biomet Holdings, Inc., Advanced Medical Technology Association and LMG Holdings, Inc. Dr. Kurdikar was previously employed as a Worldwide President-Diabetes Care by Becton, Dickinson & Co., a President & Chief Executive Officer by Cardiac Science Corp., a Vice President & General Manager by Boston Scientific Corp., a Vice President & General Manager by American Medical Systems, Inc., a Vice President by Baxter International, Inc., and a Vice President-Marketing by Infusion Systems LLC. He also served on the board at Advanced Medical Technology Association. He received his undergraduate degree from the University of Mumbai, a graduate degree from Washington State University, an MBA from Washington University in St. Louis and a doctorate degree from Purdue University.